• About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
Menu
  • About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
MPOX
JOIN
Posted on March 13, 2013September 14, 2023

Narcolepsy as an Adverse Event Following Immunization

The need for developing a case definition for narcolepsy as an adverse event following immunization (AEFI): 1.1.1. General Intr...
Read More
Posted on September 10, 2012September 14, 2023

Viscerotropic disease

Need for developing case definitions and guidelines for viscerotropic disease as an adverse event following immunization: Visce...
Read More
Posted on March 13, 2012September 14, 2023

Immunization site pain

Need for developing a case definition and guidelines for immunization site pain as an adverse event following immunization [AEFI]:...
Read More
Posted on October 10, 2011September 14, 2023

Diarrhea

Need for developing a case definition and guidelines for diarrhea as an adverse event following immunization [AEFI]: Diarrhea,...
Read More
Posted on April 13, 2008September 14, 2023

A local reaction at or near injection site

The need for developing a case definition and guidelines for a local reaction at or near the injection site, methods for the devel...
Read More
Posted on December 10, 2007September 14, 2023

Rash including mucosal involvement

Rash was the third most common adverse events reported by the U.S. Vaccine Adverse Event Reporting System (VAERS) during 1991–20...
Read More
Posted on October 13, 2007September 14, 2023

Progressive vaccinia as an adverse event following exposure to vaccinia virus

Need for developing case definitions and guidelines for adverse events following exposure to vaccinia virus: Following a declar...
Read More
Posted on August 13, 2007September 14, 2023

Fatigue

Need for developing case definitions and guidelines for fatigue as an adverse event following immunization: Fatiguing illnesses...
Read More
Posted on August 13, 2007September 14, 2023

Abscess at injection site

Need for developing case definitions and guidelines for abscess at injection site as an adverse events following immunization:...
Read More
Posted on August 1, 2007October 24, 2023

Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization

To increase comparability of vaccine clinical safety data and to improve the quality of reported data by applying the same criteri...
Read More
Previous page 1 … 4 5 6 7 8 Next page

Recent Posts

  • Safety by Numbers – February 2025February 19, 2025
  • Brighton Collaboration News — Sept 2024September 9, 2024
  • Lessons Learned from Vaccine Safety Surveillance EffortsSeptember 3, 2024
  • Comirnaty COVID-19 mRNA vaccine: standardized template with key considerations for a benefit-risk assessmentAugust 27, 2024
  • Safety by Numbers – August 2024August 14, 2024

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

  • Case Definitions
  • Safety Templates
  • Covid-19
  • Trusted Sources
Linkedin

© Brighton Collaboration  2023. All rights reserved.

  • Disclaimer and Privacy Policy